Amylx Pharmaceuticals Inc vs Quanta Services Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Quanta Services Inc trades at $682.44 (market cap $100.82B). The key difference: Quanta Services Inc is far larger — about 38.2× Amylx Pharmaceuticals Inc's market cap, and Quanta Services Inc pays a 0.07% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | PWR | |
|---|---|---|
Market Cap | $2.64B | $100.82B |
Sector | Health | Industrials |
52-Week High | $24.19 | $785.24 |
52-Week Low | $7.82 | $372.50 |
Enterprise Value | $2.39B | $106.91B |
Dividend Yield | — | 0.07% |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.
Read more on PWR →